ADC Weekly Digest - 15 Feb to 21 Feb 2025

ADC Weekly Digest - 15Feb to 21 Feb 2025

Approval
1st Trop-2 ADC Trodelvy expands indication to metastatic HR+/HER2- breast cancer
Clinical
Corbus posts first US data on challenger to Pfizer’s ADC Padcev
Deals
Radiance Biopharma enters exclusive license for ROR-1 targeted Antibody Drug Conjugate (ADC)
Deals
Sonnet BioTherapeutics unveils ADC Platform with promising preclinical results and partnership opportunities
Deals
Myris Therapeutics is developing ultra-high DAR ADCs to enable novel precision medicine treatments for cancer